NCT06521372 The Aim of This Study is to Determine if Oocyte Sorting for Group Culture Using an Artificial Intelligence Image Analysis Tool (MagentaTM) Increases the Usable Blastocyst Yield and Subsequent Pregnancy in Patients Undergoing IVF
| NCT ID | NCT06521372 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Ovation Fertility |
| Condition | Infertility Primary |
| Study Type | OBSERVATIONAL |
| Enrollment | 450 participants |
| Start Date | 2024-01-01 |
| Primary Completion | 2026-01-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 450 participants in total. It began in 2024-01-01 with a primary completion date of 2026-01-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this study is to determine if oocyte sorting for group culture using an artificial intelligence image analysis tool (MagentaTM) increases the usable blastocyst yield and subsequent pregnancy in patients undergoing IVF.
Eligibility Criteria
Inclusion Criteria: * Fresh MII oocytes * ICSI cycles with patient's or donor's sperm * Patient's or donor's oocytes * Full IVF cycle information available (including total number of oocytes retrieved, total MII oocytes, fertilization, embryo and blastocyst development, as well as ploidy status or implantation results, and 6-7 week ultrasound, if applicable) * Good quality images of MII oocytes taken with a specified camera (Basler) and Future Fertility Software * Single embryo transfers (SETs) at blastocyst stage. * Blastocyst freeze-all cycles Exclusion Criteria: * Severe male factor infertility (\<1 million motile), including surgically retrieved sperm. * ICSI cycles inseminating in vitro matured (IVM) oocytes * Rescue ICSI oocytes (oocytes failed standard IVF and are re-inseminated by ICSI) * Low quality images - Poor quality images on day of upload or before unblinding * Lack of correlating reproductive outcomes (full IVF lab results not available). * Autologous or donor frozen/warmed oocytes * Day 3 embryo transfers or cleavage stage embryo freezing * Patients with less than 6 mature oocytes
Frequently Asked Questions
Who can join the NCT06521372 clinical trial?
This trial is open to participants of all sexes, studying Infertility Primary. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06521372 currently recruiting?
Yes, NCT06521372 is actively recruiting participants. Visit ClinicalTrials.gov or contact Ovation Fertility to inquire about joining.
Where is the NCT06521372 trial being conducted?
This trial is being conducted at Las Vegas, United States, Cincinnati, United States, Nashville, United States.
Who is sponsoring the NCT06521372 clinical trial?
NCT06521372 is sponsored by Ovation Fertility. The trial plans to enroll 450 participants.